McKesson Corporation (MCK) Stock

McKesson Corporation is a prominent provider of healthcare services both in the United States and globally. Organized into four key segments, the company operates with a comprehensive approach to healthcare solutions. The U.S. Pharmaceutical segment serves as a pivotal distributor of a wide range of pharmaceutical products, including branded, generic, specialty, and biosimilar drugs, alongside over-the-counter medications. Moreover, it offers robust practice management tools, clinical support services, and business solutions tailored to community-based oncology practices and other specialty healthcare providers.

Internationally, McKesson's operations extend across 13 European countries and Canada through its International segment, which focuses on wholesale distribution and services to diverse healthcare settings, encompassing wholesale, institutional, and retail customers. Additionally, the Medical-Surgical Solutions segment specializes in medical-surgical supply distribution, logistics, and related services to healthcare providers, ensuring efficient delivery of critical medical supplies and equipment.

Innovatively addressing medication challenges, McKesson's Prescription Technology Solutions (RxTS) segment collaborates closely with biopharma companies and life sciences partners. It facilitates seamless connectivity among pharmacies, healthcare providers, payers, and patients, offering advanced access and adherence solutions. The company also provides third-party logistics and wholesale distribution support, reinforcing its commitment to enhancing healthcare delivery worldwide. Founded in 1833 and headquartered in Irving, Texas, McKesson continues to play a pivotal role in shaping the healthcare landscape through its comprehensive portfolio of services and solutions.